Industry Insights · Regulatory · Registration · Quality
Reading ISO 13485 through PDCA: the logic behind the quality system
Many read ISO 13485 as documents, audits and checklists — so the system risks becoming 'two skins'.
PDCA: the logic behind the system
For quality people, PDCA isn't a simple tool but a key to the system's logic. Grasp PDCA and the framework, and management commitment, quality policy/objectives, product-realization requirements, data analysis and CAPA stop being scattered clauses and become stages of one cycle.
Process approach: why quality connects to business
From a business view, a company gains results by consistently delivering products that meet customer needs, comply with regulation and ship reliably. So it must build interconnected processes: need identification → design → supply chain → manufacturing → quality. Each has inputs and outputs, and upstream output is often downstream input — a company is not a set of departments but a process network.
Risk thinking and 'two skins'
If any link fails, it affects not one department but the final customer experience, compliance and results. Treat the system as paperwork for audits and operation diverges from documents ('two skins'); run it through PDCA and the process approach to truly drive consistent output.
The BIO angle
FAQ
Why is PDCA the system's key?
Because management commitment, policy/objectives, product realization, data analysis and improvement are all stages of the PDCA cycle; understanding PDCA strings scattered clauses into a system.
What does the 'process approach' mean?
A company is an interconnected 'process network' where each process has inputs/outputs and upstream output is downstream input; any failure ripples to customer experience, compliance and results.
How to avoid 'two skins'?
Don't treat the system as audit paperwork; run it through PDCA and the process approach so documents and execution align.
Related reading
- FDA UDI: Labeler, DI/PI, GUDID & Direct-Marking Boundaries | BIO
- Medical-Device Biological Evaluation: A Risk-Based Evidence Route | BIO
- Medical-Device 'Product Realization' Elements: the Quality Chain from Design to Release | BIO Insights
Note: an original analysis compiled from public industry information; figures and conclusions per official/original sources. Not investment advice.
Building in China's medical-device market?
From advanced medical silicone/polymers to material selection, regulatory and supply, BIO helps global and local partners move from selection to landed supply in China.